Publication | Open Access

Identification of chemicals and their metabolites from PHY906, a Chinese medicine formulation, in the plasma of a patient treated with irinotecan and PHY906 using liquid chromatography/tandem mass spectrometry (LC/MS/MS)

BiochemistryActive IngredientMedicineMass SpectrometryMetabolomic ProfilingChinese Medicine FormulationChemical PathologyAnalytical ChemistryClinical ChemistryMetabolomicsPharmacologyPharmacokineticsChromatographyDrug Analysis